FILANA THERAPEUTICS ANNOUNCES FDA LIFT OF CLINICAL HOLD ON SIMUFILAM, ENABLING PHASE 2A STUDY IN TSC-RELATED EPILEPSY

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.